| Literature DB >> 31150155 |
Janis Fricke1, Alexander Sherwood2, Robert Kargbo2, Andrew Orry3, Felix Blei1, Andreas Naschberger4, Bernhard Rupp4,5, Dirk Hoffmeister1.
Abstract
Psilocybin and its direct precursor baeocystin are indole alkaloids of psychotropic Psilocybe mushrooms. The pharmaceutical interest in psilocybin as a treatment option against depression and anxiety is currently being investigated in advanced clinical trials. Here, we report a biocatalytic route to synthesize 6-methylated psilocybin and baeocystin from 4-hydroxy-6-methyl-l-tryptophan, which was decarboxylated and phosphorylated by the Psilocybe cubensis biosynthesis enzymes PsiD and PsiK. N-Methylation was catalyzed by PsiM. We further present an in silico structural model of PsiM that revealed a well-conserved SAM-binding core along with peripheral nonconserved elements that likely govern substrate preferences.Entities:
Keywords: baeocystin; biosynthesis; enzymes; methyltransferase; psilocybin
Mesh:
Substances:
Year: 2019 PMID: 31150155 DOI: 10.1002/cbic.201900358
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164